Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of immune tolerance after living donor liver transplantation with inducible inhibitory T cells
jRCT1030200339Active, not recruiting
- Sponsor
- Juntendo University
- Start
- Jan 2021
- Countries
- 1
01
Overview
Open-label trial in liver transplant recipient (LTR) and Hepatic transplant rejection (LTR) (2 arms), sponsored by Juntendo University. Primary endpoints: Change in peripheral blood regulatory T cells, Graft-infiltrating tolerant system cells and 9 more. Started Jan 2021; status: active, not recruiting.
02
Conditions
liver transplant recipient (LTR)Hepatic transplant rejection (LTR)
Beyond the preview
Go deeper on jRCT1030200339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030200339.